Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 315 entries
Sorted by: Best Match Show Resources per page
Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia.

Clinical and molecular allergy : CMA

Recto MT, Gabriel MT, Kulthanan K, Tantilipikorn P, Aw DC, Lee TH, Chwen CC, Mutusamy S, Hao NT, Quang VT, Canonica GW.
PMID: 29118675
Clin Mol Allergy. 2017 Nov 01;15:19. doi: 10.1186/s12948-017-0074-3. eCollection 2017.

BACKGROUND: Allergic diseases are on the rise in many parts of the world, including the Asia-Pacific (APAC) region. Second-generation antihistamines are the first-line treatment option in the management of allergic rhinitis and urticaria. International guidelines describe the management of...

Cite
Recto MT, Gabriel MT, Kulthanan K, et al. Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia. Clin Mol Allergy. 2017;15:19doi: 10.1186/s12948-017-0074-3.
Recto, M. T., Gabriel, M. T., Kulthanan, K., Tantilipikorn, P., Aw, D. C., Lee, T. H., Chwen, C. C., Mutusamy, S., Hao, N. T., Quang, V. T., & Canonica, G. W. (2017). Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia. Clinical and molecular allergy : CMA, 1519. https://doi.org/10.1186/s12948-017-0074-3
Recto, Marysia Tiongco, et al. "Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia." Clinical and molecular allergy : CMA vol. 15 (2017): 19. doi: https://doi.org/10.1186/s12948-017-0074-3
Recto MT, Gabriel MT, Kulthanan K, Tantilipikorn P, Aw DC, Lee TH, Chwen CC, Mutusamy S, Hao NT, Quang VT, Canonica GW. Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia. Clin Mol Allergy. 2017 Nov 01;15:19. doi: 10.1186/s12948-017-0074-3. eCollection 2017. PMID: 29118675; PMCID: PMC5664819.
Copy Download .nbib Format: NLM
The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey.

Clinical and translational allergy

Price D, Scadding G, Ryan D, Bachert C, Canonica GW, Mullol J, Klimek L, Pitman R, Acaster S, Murray R, Bousquet J.
PMID: 26583068
Clin Transl Allergy. 2015 Nov 18;5:39. doi: 10.1186/s13601-015-0083-6. eCollection 2015.

BACKGROUND: The affliction of allergic rhinitis (AR) has been trivialised in the past. Recent initiatives by the European Academy of Allergy & Clinical Immunology and by the EU parliament seek to rectify that situation. The aim of this study...

Cite
Price D, Scadding G, Ryan D, et al. The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy. 2015;5:39doi: 10.1186/s13601-015-0083-6.
Price, D., Scadding, G., Ryan, D., Bachert, C., Canonica, G. W., Mullol, J., Klimek, L., Pitman, R., Acaster, S., Murray, R., & Bousquet, J. (2015). The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clinical and translational allergy, 539. https://doi.org/10.1186/s13601-015-0083-6
Price, David, et al. "The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey." Clinical and translational allergy vol. 5 (2015): 39. doi: https://doi.org/10.1186/s13601-015-0083-6
Price D, Scadding G, Ryan D, Bachert C, Canonica GW, Mullol J, Klimek L, Pitman R, Acaster S, Murray R, Bousquet J. The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy. 2015 Nov 18;5:39. doi: 10.1186/s13601-015-0083-6. eCollection 2015. PMID: 26583068; PMCID: PMC4650835.
Copy Download .nbib Format: NLM
Prevalence, serotyping and molecular characterization of Vibrio parahaemolyticus in mussels from Italian growing areas, Adriatic Sea.

Environmental microbiology reports

Ottaviani D, Leoni F, Rocchegiani E, Canonico C, Potenziani S, Santarelli S, Masini L, Mioni R, Carraturo A.
PMID: 23766016
Environ Microbiol Rep. 2010 Feb;2(1):192-7. doi: 10.1111/j.1758-2229.2010.00134.x.

The aims of this study were to investigate the prevalence of total and pathogenic Vibrio parahaemolyticus strains in Italian mussels from different geographical areas of the Adriatic Sea and to determine their serotypes, toxigenic profiles and pandemic potential. Out...

Cite
Ottaviani D, Leoni F, Rocchegiani E, et al. Prevalence, serotyping and molecular characterization of Vibrio parahaemolyticus in mussels from Italian growing areas, Adriatic Sea. Environ Microbiol Rep. 2010;2(1):192-7doi: 10.1111/j.1758-2229.2010.00134.x.
Ottaviani, D., Leoni, F., Rocchegiani, E., Canonico, C., Potenziani, S., Santarelli, S., Masini, L., Mioni, R., & Carraturo, A. (2010). Prevalence, serotyping and molecular characterization of Vibrio parahaemolyticus in mussels from Italian growing areas, Adriatic Sea. Environmental microbiology reports, 2(1), 192-7. https://doi.org/10.1111/j.1758-2229.2010.00134.x
Ottaviani, Donatella, et al. "Prevalence, serotyping and molecular characterization of Vibrio parahaemolyticus in mussels from Italian growing areas, Adriatic Sea." Environmental microbiology reports vol. 2,1 (2010): 192-7. doi: https://doi.org/10.1111/j.1758-2229.2010.00134.x
Ottaviani D, Leoni F, Rocchegiani E, Canonico C, Potenziani S, Santarelli S, Masini L, Mioni R, Carraturo A. Prevalence, serotyping and molecular characterization of Vibrio parahaemolyticus in mussels from Italian growing areas, Adriatic Sea. Environ Microbiol Rep. 2010 Feb;2(1):192-7. doi: 10.1111/j.1758-2229.2010.00134.x. PMID: 23766016.
Copy Download .nbib Format: NLM
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress.

Clinical and translational allergy

Hellings PW, Muraro A, Fokkens W, Mullol J, Bachert C, Canonica GW, Price D, Papadopoulos N, Scadding G, Rasp G, Demoly P, Murray R, Bousquet J.
PMID: 26509001
Clin Transl Allergy. 2015 Oct 27;5:36. doi: 10.1186/s13601-015-0080-9. eCollection 2015.

BACKGROUND: The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doctors' perception of a...

Cite
Hellings PW, Muraro A, Fokkens W, et al. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015;5:36doi: 10.1186/s13601-015-0080-9.
Hellings, P. W., Muraro, A., Fokkens, W., Mullol, J., Bachert, C., Canonica, G. W., Price, D., Papadopoulos, N., Scadding, G., Rasp, G., Demoly, P., Murray, R., & Bousquet, J. (2015). A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clinical and translational allergy, 536. https://doi.org/10.1186/s13601-015-0080-9
Hellings, Peter W, et al. "A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress." Clinical and translational allergy vol. 5 (2015): 36. doi: https://doi.org/10.1186/s13601-015-0080-9
Hellings PW, Muraro A, Fokkens W, Mullol J, Bachert C, Canonica GW, Price D, Papadopoulos N, Scadding G, Rasp G, Demoly P, Murray R, Bousquet J. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015 Oct 27;5:36. doi: 10.1186/s13601-015-0080-9. eCollection 2015. PMID: 26509001; PMCID: PMC4621924.
Copy Download .nbib Format: NLM
CD4(+)CD25(high)CD127(-) regulatory T-cells in COPD: smoke and drugs effect.

The World Allergy Organization journal

Chiappori A, Folli C, Balbi F, Caci E, Riccio AM, De Ferrari L, Melioli G, Braido F, Canonica GW.
PMID: 26904157
World Allergy Organ J. 2016 Feb 12;9:5. doi: 10.1186/s40413-016-0095-2. eCollection 2016.

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder characterized by poorly reversible airway obstruction and its pathogenesis remains largely misunderstood. Local changes of regulatory T-cell populations in the lungs of COPD patients have been demonstrated although...

Cite
Chiappori A, Folli C, Balbi F, et al. CD4(+)CD25(high)CD127(-) regulatory T-cells in COPD: smoke and drugs effect. World Allergy Organ J. 2016;9:5doi: 10.1186/s40413-016-0095-2.
Chiappori, A., Folli, C., Balbi, F., Caci, E., Riccio, A. M., De Ferrari, L., Melioli, G., Braido, F., & Canonica, G. W. (2016). CD4(+)CD25(high)CD127(-) regulatory T-cells in COPD: smoke and drugs effect. The World Allergy Organization journal, 95. https://doi.org/10.1186/s40413-016-0095-2
Chiappori, Alessandra, et al. "CD4(+)CD25(high)CD127(-) regulatory T-cells in COPD: smoke and drugs effect." The World Allergy Organization journal vol. 9 (2016): 5. doi: https://doi.org/10.1186/s40413-016-0095-2
Chiappori A, Folli C, Balbi F, Caci E, Riccio AM, De Ferrari L, Melioli G, Braido F, Canonica GW. CD4(+)CD25(high)CD127(-) regulatory T-cells in COPD: smoke and drugs effect. World Allergy Organ J. 2016 Feb 12;9:5. doi: 10.1186/s40413-016-0095-2. eCollection 2016. PMID: 26904157; PMCID: PMC4751712.
Copy Download .nbib Format: NLM
Gallstone ileus without bilioenteric fistula years after bypass surgery for Crohn's disease. Case report and clues to etiology of a neglected cause of obstruction.

International journal of surgery case reports

Pellino G, Candilio G, De Fatico GS, Marcellinaro R, Formicola GC, Volpicelli A, Sciaudone G, Riegler G, Canonico S, Selvaggi F.
PMID: 25770438
Int J Surg Case Rep. 2015;9:134-8. doi: 10.1016/j.ijscr.2015.03.004. Epub 2015 Mar 07.

INTRODUCTION: Gallstone ileus is a very rare cause of bowel obstruction. Patients suffering from Crohn's disease are at increased risk of developing gallstone disease, especially when terminal ileum is involved. Gallstone ileus can occur, but etiology remains controversial. We...

Cite
Pellino G, Candilio G, De Fatico GS, et al. Gallstone ileus without bilioenteric fistula years after bypass surgery for Crohn's disease. Case report and clues to etiology of a neglected cause of obstruction. Int J Surg Case Rep. 2015;9:134-8doi: 10.1016/j.ijscr.2015.03.004.
Pellino, G., Candilio, G., De Fatico, G. S., Marcellinaro, R., Formicola, G. C., Volpicelli, A., Sciaudone, G., Riegler, G., Canonico, S., & Selvaggi, F. (2015). Gallstone ileus without bilioenteric fistula years after bypass surgery for Crohn's disease. Case report and clues to etiology of a neglected cause of obstruction. International journal of surgery case reports, 9134-8. https://doi.org/10.1016/j.ijscr.2015.03.004
Pellino, Gianluca, et al. "Gallstone ileus without bilioenteric fistula years after bypass surgery for Crohn's disease. Case report and clues to etiology of a neglected cause of obstruction." International journal of surgery case reports vol. 9 (2015): 134-8. doi: https://doi.org/10.1016/j.ijscr.2015.03.004
Pellino G, Candilio G, De Fatico GS, Marcellinaro R, Formicola GC, Volpicelli A, Sciaudone G, Riegler G, Canonico S, Selvaggi F. Gallstone ileus without bilioenteric fistula years after bypass surgery for Crohn's disease. Case report and clues to etiology of a neglected cause of obstruction. Int J Surg Case Rep. 2015;9:134-8. doi: 10.1016/j.ijscr.2015.03.004. Epub 2015 Mar 07. PMID: 25770438; PMCID: PMC4392375.
Copy Download .nbib Format: NLM
Anomalous LO phonon lifetime in AlAs.

Physical review letters

Canonico M, Poweleit C, Menéndez J, Debernardi A, Johnson SR, Zhang YH.
PMID: 12059485
Phys Rev Lett. 2002 May 27;88(21):215502. doi: 10.1103/PhysRevLett.88.215502. Epub 2002 May 14.

The temperature dependence of the frequencies and linewidths of the Raman-active longitudinal optical (LO) phonons in GaAs and AlAs have been measured. The low-temperature lifetime of the LO phonon in AlAs is found to be 9.7 ps, very close...

Cite
Canonico M, Poweleit C, Menéndez J, et al. Anomalous LO phonon lifetime in AlAs. Phys Rev Lett. 2002;88(21):215502doi: 10.1103/PhysRevLett.88.215502.
Canonico, M., Poweleit, C., Menéndez, J., Debernardi, A., Johnson, S. R., & Zhang, Y. H. (2002). Anomalous LO phonon lifetime in AlAs. Physical review letters, 88(21), 215502. https://doi.org/10.1103/PhysRevLett.88.215502
Canonico, M, et al. "Anomalous LO phonon lifetime in AlAs." Physical review letters vol. 88,21 (2002): 215502. doi: https://doi.org/10.1103/PhysRevLett.88.215502
Canonico M, Poweleit C, Menéndez J, Debernardi A, Johnson SR, Zhang YH. Anomalous LO phonon lifetime in AlAs. Phys Rev Lett. 2002 May 27;88(21):215502. doi: 10.1103/PhysRevLett.88.215502. Epub 2002 May 14. PMID: 12059485.
Copy Download .nbib Format: NLM
Appropriate use of anabolic treatment for severe osteoporosis.

Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases

Adami S, Brandi ML, Canonico PL, Minisola G, Minisola S, Tarantino U.
PMID: 22460015
Clin Cases Miner Bone Metab. 2010 May;7(2):114-22.

Osteoporotic fractures remain a major public health problem for their correlated morbidity and mortality. The primary aim of therapy must be the prevention of the first fragility fracture and avoiding subsequent fractures in patients who already have an existing...

Cite
Adami S, Brandi ML, Canonico PL, et al. Appropriate use of anabolic treatment for severe osteoporosis. Clin Cases Miner Bone Metab. 2010;7(2):114-22
Adami, S., Brandi, M. L., Canonico, P. L., Minisola, G., Minisola, S., & Tarantino, U. (2010). Appropriate use of anabolic treatment for severe osteoporosis. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 7(2), 114-22.
Adami, Silvano, et al. "Appropriate use of anabolic treatment for severe osteoporosis." Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases vol. 7,2 (2010): 114-22.
Adami S, Brandi ML, Canonico PL, Minisola G, Minisola S, Tarantino U. Appropriate use of anabolic treatment for severe osteoporosis. Clin Cases Miner Bone Metab. 2010 May;7(2):114-22. PMID: 22460015; PMCID: PMC3004457.
Copy Download .nbib Format: NLM
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide.

Therapeutics and clinical risk management

Braido F, Lagasio C, Piroddi I, Baiardini I, Canonica G.
PMID: 18728855
Ther Clin Risk Manag. 2008 Apr;4(2):353-61. doi: 10.2147/tcrm.s1266.

Allergic rhinitis (AR) is a chronic inflammatory respiratory disease affecting 5%-50% of the worldwide population and its prevalence is increasing (Herman 2007). In addition, AR is associated with asthma and other co-morbidities such as conjunctivitis and sinusitis. The main...

Cite
Braido F, Lagasio C, Piroddi I, et al. New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. Ther Clin Risk Manag. 2008;4(2):353-61doi: 10.2147/tcrm.s1266.
Braido, F., Lagasio, C., Piroddi, I., Baiardini, I., & Canonica, G. (2008). New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. Therapeutics and clinical risk management, 4(2), 353-61. https://doi.org/10.2147/tcrm.s1266
Braido, F, et al. "New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide." Therapeutics and clinical risk management vol. 4,2 (2008): 353-61. doi: https://doi.org/10.2147/tcrm.s1266
Braido F, Lagasio C, Piroddi I, Baiardini I, Canonica G. New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. Ther Clin Risk Manag. 2008 Apr;4(2):353-61. doi: 10.2147/tcrm.s1266. PMID: 18728855; PMCID: PMC2504079.
Copy Download .nbib Format: NLM
Local nasal specific immunotherapy for allergic rhinitis.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Passalacqua G, Canonica GW.
PMID: 20525156
Allergy Asthma Clin Immunol. 2006 Sep 15;2(3):117-23. doi: 10.1186/1710-1492-2-3-117. Epub 2006 Sep 15.

The possibility of producing local hyposensitization by administering allergens via mucosal routes was envisaged at the beginning of 1900, and local nasal immunotherapy has been extensively studied since the 1970s. Presently, there are 21 randomized controlled trials being conducted...

Cite
Passalacqua G, Canonica GW. Local nasal specific immunotherapy for allergic rhinitis. Allergy Asthma Clin Immunol. 2006;2(3):117-23doi: 10.1186/1710-1492-2-3-117.
Passalacqua, G., & Canonica, G. W. (2006). Local nasal specific immunotherapy for allergic rhinitis. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2(3), 117-23. https://doi.org/10.1186/1710-1492-2-3-117
Passalacqua, Giovanni, and Canonica, Giorgio Walter. "Local nasal specific immunotherapy for allergic rhinitis." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 2,3 (2006): 117-23. doi: https://doi.org/10.1186/1710-1492-2-3-117
Passalacqua G, Canonica GW. Local nasal specific immunotherapy for allergic rhinitis. Allergy Asthma Clin Immunol. 2006 Sep 15;2(3):117-23. doi: 10.1186/1710-1492-2-3-117. Epub 2006 Sep 15. PMID: 20525156; PMCID: PMC2876180.
Copy Download .nbib Format: NLM
Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper.

The World Allergy Organization journal

Passalacqua G, Compalati E, Canonica GW.
PMID: 23282652
World Allergy Organ J. 2010 Jul;3(7):216-9. doi: 10.1097/WOX.0b013e3181e8d19c.

Sublingual immunotherapy (SLIT) is a matter of only 20 years. Nonetheless, in this short period of time more than 60 randomized double blind placebo-controlled trials have been published, in addition to postmarketing surveillance studies and meta-analyses. The wide diffusion...

Cite
Passalacqua G, Compalati E, Canonica GW. Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper. World Allergy Organ J. 2010;3(7):216-9doi: 10.1097/WOX.0b013e3181e8d19c.
Passalacqua, G., Compalati, E., & Canonica, G. W. (2010). Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper. The World Allergy Organization journal, 3(7), 216-9. https://doi.org/10.1097/WOX.0b013e3181e8d19c
Passalacqua, Giovanni, et al. "Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper." The World Allergy Organization journal vol. 3,7 (2010): 216-9. doi: https://doi.org/10.1097/WOX.0b013e3181e8d19c
Passalacqua G, Compalati E, Canonica GW. Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper. World Allergy Organ J. 2010 Jul;3(7):216-9. doi: 10.1097/WOX.0b013e3181e8d19c. PMID: 23282652; PMCID: PMC3651141.
Copy Download .nbib Format: NLM
May we strengthen the human natural defenses with bacterial lysates?.

The World Allergy Organization journal

Villa E, Garelli V, Braido F, Melioli G, Canonica GW.
PMID: 23282746
World Allergy Organ J. 2010 Aug;3(8):S17-23. doi: 10.1097/WOX.0b013e3181ee0cfd.

During the last twenty years bacterial lysates have gained a new interest and their use has obtained a progressively larger consensus in the medical practice. They are commonly used as immunomodulators, in order to up-regulate immune responses against infectious...

Cite
Villa E, Garelli V, Braido F, et al. May we strengthen the human natural defenses with bacterial lysates?. World Allergy Organ J. 2010;3(8):S17-23doi: 10.1097/WOX.0b013e3181ee0cfd.
Villa, E., Garelli, V., Braido, F., Melioli, G., & Canonica, G. W. (2010). May we strengthen the human natural defenses with bacterial lysates?. The World Allergy Organization journal, 3(8), S17-23. https://doi.org/10.1097/WOX.0b013e3181ee0cfd
Villa, Elisa, et al. "May we strengthen the human natural defenses with bacterial lysates?." The World Allergy Organization journal vol. 3,8 (2010): S17-23. doi: https://doi.org/10.1097/WOX.0b013e3181ee0cfd
Villa E, Garelli V, Braido F, Melioli G, Canonica GW. May we strengthen the human natural defenses with bacterial lysates?. World Allergy Organ J. 2010 Aug;3(8):S17-23. doi: 10.1097/WOX.0b013e3181ee0cfd. PMID: 23282746; PMCID: PMC3666147.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 315 entries